Subscribe To
Samsung's irregular heart rhythm notification feature for the galaxy watch receives fda clearance
Samsung announced today that its Irregular Heart Rhythm Notification feature for the Galaxy Watch has received FDA clearance. Together with the Galaxy...
May 8, 2023, 10:51 am
Intravascular ultrasound market poised for substantial growth, forecasted to surpass usd 1296 million by 2032 | market.us report
The Intravascular Ultrasound (IVUS) industry is set to experience significant growth in the coming years due to factors such as the rising prevalence ...
May 8, 2023, 9:06 am
Poor-quality diet tied to higher risk for adverse cad, pad outcomes
Poor diet quality is independently associated with a higher risk for recurrent major adverse cardiovasc...
May 5, 2023, 5:29 pm
Bridgebio pharma reports first quarter 2023 financial results and business update
– Phase 3 ATTRibute-CM registrational trial of acoramidis for transthyretin amyloid cardiomyopathy (A...
May 4, 2023, 11:30 am
Biocardia to host q1 2023 financial results and corporate update conference call on may 10, 2023
SUNNYVALE, Calif., May 03, 2023 (GLOBE NEWSWIRE) — BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the tr...
May 4, 2023, 12:00 am
Biocardia to host q1 2023 financial results and corporate update conference call on may 10, 2023
SUNNYVALE, Calif., May 03, 2023 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [NASDAQ:BCDA], a developer of cellular and cell-derived therapeutics for the tre...
May 3, 2023, 8:00 pm
Dupont to acquire spectrum plastics from aea investors for $1.75 billion in cash
DuPont de Nemours Inc. DD said Tuesday it has reached an agreement to acquire Spectrum Plastics Group from AEA Investors for $1.75 billion cash. Spect...
May 2, 2023, 6:10 am
Merit medical (mmsi) tops q1 earnings estimates, ups fy23 view
Merit Medical (MMSI) benefits from revenue growth in both segments and all product categories within its cardi...
April 28, 2023, 3:12 pm
Biocardia presentations at next generation cardiovascular drug development summit now available
SUNNYVALE, Calif., April 28, 2023 (GLOBE NEWSWIRE) — BioCardia®, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for the...
April 28, 2023, 11:00 am
Functional foods market set to surpass a valuation of us$ 678.3 billion by 2032 driven rising health awareness | report by market.us
The global functional foods market has a significant share dedicated to cardio health, owing to the inc...
April 27, 2023, 7:03 am
Boston scientific reports 1q sales and earnings above guidance
Boston Scientific (NYSE:BSX) has reported first-quarter revenue and earnings that beat its own guidance as well as Wall Street's expectations due to s...
April 26, 2023, 8:08 am
Stethoscope market size to hit usd 991.6 mn by 2032 due to rising cardiovascular & respiratory disorders | tmr study
The prominent players operating in the global Stethoscopes market are 3M, Medline Industries, Inc., Welch Allyn, GF Health Products, Inc., Rudolf Ries...
April 19, 2023, 2:30 pm
Keros therapeutics appoints alpna seth, ph.d., to its board of directors
LEXINGTON, Mass., April 19, 2023 (GLOBE NEWSWIRE) — Keros Therapeutics, Inc. (“Keros” or the “Company”) (Nasdaq: KROS), a clinical-stage bio...
April 19, 2023, 12:00 pm
Daxor corporation to exhibit at the medaxiom cardiovascular transforum conference spring’23 to advance awareness and further adoption of daxor’s blood volume diagnostic (bva-100®)
Expert Users to Present “Blood Volume Analysis – Breaking the Heart Failure Cycle” Oak Ridge, TN, April 17, 2023 (GLOBE NEWSWIRE) — Daxor Corp...
April 17, 2023, 12:00 pm
Verve: spiffy biotech that cathie wood bought, initiating with a hold rating
Verve Therapeutics, Inc. is developing a CRISPR-based editing gene therapy for cardiovascular diseases....
April 14, 2023, 5:40 pm
Shareholder investigation: halper sadeh llc investigates csii, nuva, osh, sumo
NEW YORK, April 13, 2023 (GLOBE NEWSWIRE) — Halper Sadeh LLC, an investor rights law firm, is investigating the following companies for potential vi...
April 13, 2023, 4:49 pm
cardiovascular systems (csii) finishes eclipse trial enrollment
cardiovascular Systems' (CSII) ECLIPSE clinical trial data is likely to help physicians form an optimal...
April 5, 2023, 10:40 am
Amarin stock falls after ceo mikhail resigns, company disputes ceo asserting of entitlement to severance
Shares of Amarin Corp. AMRN, -5.19% rose dropped 5.5% toward a near three-month low in premarket trading Friday, after the biopharmaceutical company f...
March 31, 2023, 10:17 am
Chronic total occlusion devices market to reach usd 2.9 bn by 2031 | tmr study
The global chronic total occlusion (CTO) devices market growth is driven by the rise in prevalence of cardio...
March 31, 2023, 1:30 am
cardiol therapeutics offers an update on operations as it advances the development of its lead drug candidate cardiolrx
cardiol Therapeutics (TSX:CRDL, NASDAQ:CRDL) Inc CEO David Elsley told investors in a year-end 2022 upd...
March 29, 2023, 5:11 pm